Pregnenolone

Does taking pregnenolone improve memory and mood?

Pregnenolone may help memory in schizophrenia and mood in bipolar depression, but data in healthy adults are limited.

Pregnenolone is the starting point for nearly all your steroid hormones — your body makes it from cholesterol and then converts it into progesterone, DHEA, cortisol, estrogen, and testosterone, among others. Levels peak in your twenties and steadily decline with age. But pregnenolone isn't just a passive raw material: it acts as a neurosteroid, directly influencing memory, mood, and brain function. Low levels have been linked to cognitive decline, mood disorders, and poor stress resilience1,2.

What you can do

  • If used, take it in the morning (it can be stimulating); studies gave 50–500 mg a day, practitioners typically 10–50 mg2,3.
  • Ask a doctor for a full hormone panel periodically during long-term use, since pregnenolone converts into other hormones unpredictably.

Be careful if

  • Contraindicated in hormone-sensitive conditions: breast cancer, endometriosis, prostate cancer and uterine fibroids.
  • It can shift downstream hormones (progesterone, DHEA, cortisol, estrogen, testosterone) unpredictably, so some people may make more estrogen or cortisol.
  • It is not a substitute for psychiatric care; the bipolar trial used it as an add-on to treatment3.
How it works What it does in your body, in plain words 2 min

Pregnenolone is synthesized in the mitochondria of cells in the adrenal glands, brain, and gonads, where an enzyme called CYP11A1 cleaves the side chain off cholesterol. From there, it enters the steroidogenesis cascade — the branching pathway that produces all your sex and stress hormones.

What makes pregnenolone unusual is that it doesn't just serve as a hormonal raw material. It is a neurosteroid: it is produced within the brain itself and acts directly on neurons and synapses. Pregnenolone sulfate (the sulfated form that predominates in the central nervous system) modulates GABA-A receptors (reducing inhibitory signaling) and NMDA receptors (enhancing excitatory signaling), which together sharpen alertness, attention, and memory encoding1.

The Hormone Cascade

A single molecule of pregnenolone can become many different things depending on which enzymes are active:

  • Progesterone — regulates the menstrual cycle, supports pregnancy, calms the nervous system
  • DHEA — the upstream precursor to estrogen and testosterone
  • Cortisol — the primary stress hormone
  • Aldosterone — regulates sodium and blood pressure

This means pregnenolone supplementation can shift downstream hormone levels in ways that are difficult to predict without testing. It tends to convert preferentially toward whatever pathways the body needs most, though this is influenced by individual genetics and enzyme activity.

Age-Related Decline

Pregnenolone production drops significantly with age — mirroring the well-documented decline of DHEA (see our DHEA page). By age 75, pregnenolone levels are roughly 60% lower than in young adulthood. This decline coincides with the well-known pattern of hormonal aging: reduced resilience to stress, worsening sleep quality, declining libido, and reduced cognitive sharpness.

Dosage

Research studies have used doses ranging from 50 mg to 500 mg daily. For general supplementation, most practitioners use 10–50 mg per day, ideally taken in the morning (as it can be stimulating). Because it affects downstream hormones, periodic blood testing — including a full hormone panel — is advisable when supplementing long-term.

Cross-reference: See our DHEA page for how the closely related DHEA fits into this same cascade, and the adrenal health page for the broader HPA axis context.

The evidence The studies, what they found, and how much to trust them 2 min · 4 sources

Cognitive Function

The strongest mechanistic basis for pregnenolone's cognitive effects comes from studies of its sulfated form. A review of animal and human data found that pregnenolone sulfate enhances acetylcholine release in key memory centers including the hippocampus and prefrontal cortex, and blocks the memory-impairing effects of scopolamine (a muscarinic receptor blocker)1. In animal models, direct administration of pregnenolone sulfate improves spatial learning and retention in dose-dependent fashion.

In humans, a proof-of-concept randomized controlled trial (n=21, 8 weeks, pregnenolone up to 500 mg/day) in patients with schizophrenia showed improvements in verbal memory, working memory, and attention, with z-score improvements 0.61 greater than placebo on a composite cognitive battery2. Effect sizes were modest but meaningful for a proof-of-concept design, and tolerability was good. These findings suggest pregnenolone may have a role in supporting cognitive performance when levels are depleted, though data in healthy adults remain limited.

Mood and Depression

A randomized, double-blind, placebo-controlled trial (n=80, 12 weeks) tested pregnenolone (titrated to 500 mg/day) as adjunct therapy for bipolar depression3. Remission rates were significantly higher in the pregnenolone group (61%) compared to placebo (37%), and the supplement was well tolerated. Depression symptom scores (MADRS) showed greater improvement in the active arm, with women showing a more robust response than men. Mechanistically, the authors attributed part of the effect to conversion of pregnenolone into allopregnanolone — a potent GABA-A modulator that has antidepressant properties.

The stress-reducing effects also appear relevant to substance use: a trial in individuals with cocaine use disorder found that pregnenolone significantly reduced cue-induced cocaine craving and self-reported anxiety compared to placebo.

Anti-Inflammatory Activity

Preclinical research has shown that pregnenolone can suppress innate immune signaling by promoting degradation of TRAF6, a key adaptor protein in the Toll-like receptor pathway4. This anti-inflammatory mechanism is distinct from its hormonal actions and may contribute to neuroprotection. Whether this translates clinically at supplemental doses is not yet established.

Evidence Strength and Limitations

The evidence base for pregnenolone supplementation is promising but early. Most trials are small, short-duration proof-of-concept studies in clinical populations (schizophrenia, bipolar disorder) rather than healthy adults. The cognitive and mood effects are plausible given well-understood mechanisms, but confirming benefit in general populations requires larger trials. The unpredictable downstream hormone conversion also means individual responses can vary considerably — some people may produce more estrogen or cortisol, others more DHEA or progesterone. Supplementation in hormone-sensitive conditions (breast cancer, endometriosis, prostate cancer, uterine fibroids) is contraindicated.

  1. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging. Vallee M, Mayo W, Le Moal M. Brain Research Reviews, 2001. PubMed 11744095
  2. Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. Marx CE, Keefe RS, Buchanan RW, et al.. Neuropsychopharmacology, 2009. PubMed 19339966
  3. A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. Brown ES, Park J, Marx CE, et al.. Neuropsychopharmacology, 2014. PubMed 24917198
  4. The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation. Murugan S, Jakka P, Namani S, Mujumdar V, Radhakrishnan G. Journal of Biological Chemistry, 2019. PubMed 30647133

Every change to this page is tracked in version control. View edit history. If you have conflicting research, we want to hear about it.

Spotted something wrong or out of date? Suggest a change.

Weekly research digest

New topics and updated research, once a week when there's something new. How it works